AI and Genomics in Drug Discovery Accelerating Cancer Treatment Development
This session focuses on how AI and genomic data are accelerating the development of new cancer drugs. Attendees will learn how AI models can predict the efficacy of compounds, identify biomarkers, and expedite clinical trials for novel therapies.
Key Topics:
- AI-driven drug discovery pipelines
- Genomic biomarkers for drug efficacy and toxicity prediction
- Speeding up clinical trials with AI integration
- The future of precision oncology drug development
